Table 2.
Clinical parameters and renal metrics at different furosemide dosages in the study populations
| Parameters | Group 1 (125 mg) (N = 14) | Group 2 (250 mg) (N = 13) | Group 3 (500 mg) (N = 13) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Normal saline | Hypertonic saline | P | Normal saline | Hypertonic saline | P | Normal saline | Hypertonic saline | P | |
| SBP (mm Hg) | 128 ± 14 | 117 ± 14 | 0.04 | 128 ± 19 | 119 ± 16 | 0.2 | 128 ± 15 | 118 ± 10 | 0.05 |
| HR (beats/min) | 76 ± 13 | 72 ± 9 | 0.3 | 82 ± 16 | 73 ± 13 | 0.1 | 81 ± 12 | 68 ± 7 | 0.003 |
| Serum sodium (mEq/L) | 141 ± 3 | 140 ± 3 | 0.4 | 138 ± 3 | 140 ± 2 | 0.05 | 140 ± 3 | 141 ± 2 | 0.32 |
| BUN (mg/dL) | 64 ± 26 | 60 ± 23 | 0.6 | 64 ± 32 | 79 ± 29 | 0.2 | 69 ± 35 | 87 ± 33 | 0.19 |
| Creatinine (mg/dL) | 1.1 ± 0.4 | 1.0 ± 0.4 | 0.5 | 1.2 ± 0.5 | 1.2 ± 0.3 | 1 | 1.2 ± 0.4 | 1.4 ± 0.4 | 0.21 |
Values are presented as mean ± standard deviation. Normal saline (0.9%) and hypertonic Saline (1.4%). BUN blood urea nitrogen, HR heart rate SBP systolic blood pressure